Pucotenlimab
2025-FXY-301
Phase 2 small_molecule active
Quick answer
Pucotenlimab for Colorectal Cancer (CRC) is a Phase 2 program (small_molecule) at Sun Yat-sen University with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sun Yat-sen University
- Indication
- Colorectal Cancer (CRC)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active